Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes
- PMID: 37517452
- DOI: 10.1016/j.jhep.2023.07.011
Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes
Abstract
Background & aims: Acute-on-chronic liver failure (ACLF) is a clinical syndrome associated with high short-term mortality in patients with chronic liver disease. Chronic hepatitis B is the main cause of ACLF (HBV-ACLF) in China and other Asian countries. To improve disease management and survival for patients with ACLF, we aimed to discover novel biomarkers to enhance HBV-ACLF diagnosis and prognostication.
Methods: We performed a metabolomics profiling of 1,024 plasma samples collected from patients with HBV-related chronic liver disease with acute exacerbation at hospital admission in a multi-year and multi-center prospective study (367 ACLF and 657 non-ACLF). The samples were randomly separated into equal halves as a discovery set and a validation set. We identified metabolites associated with 90-day mortality in the ACLF group and the progression to ACLF within 28 days in the non-ACLF group (pre-ACLF) using statistical analysis and machine learning. We developed diagnostic algorithms in the discovery set and used these to assess the findings in the validation set.
Results: ACLF significantly altered the plasma metabolome, particularly in membrane lipid metabolism, steroid hormones, oxidative stress pathways, and energy metabolism. Numerous metabolites were significantly associated with 90-day mortality in the ACLF group and/or pre-ACLF in the non-ACLF group. We developed algorithms for the prediction of 90-day mortality in patients with ACLF (area under the curve 0.87 and 0.83 for the discovery set and validation set, respectively) and the diagnosis of pre-ACLF (area under the curve 0.94 and 0.88 for the discovery set and validation set, respectively). To translate our discoveries into practical clinical tests, we developed targeted assays using liquid chromatography-mass spectrometry.
Conclusions: Based on novel metabolite biomarkers, we established tests for HBV-related ACLF with higher accuracy than existing methods.
Clinical trial number: NCT02457637 and NCT03641872.
Impact and implications: Acute-on-chronic liver failure (ACLF) is a clinical syndrome associated with high short-term mortality affecting 25% of patients hospitalized with cirrhosis. Chronic hepatitis B is the main etiology of ACLF in China and other Asian counties. There is currently no effective therapy. Early diagnosis and accurate prognostication are critical for improving clinical outcomes in patients with ACLF. Based on novel metabolite biomarkers, we developed liquid chromatography-mass spectrometry tests with improved accuracy for the early diagnosis and prognostication of HBV-related ACLF. The liquid chromatography-mass spectrometry tests can be implemented in clinical labs and used by physicians to triage patients with HBV-related ACLF to ensure optimized clinical management.
Keywords: clinical test development; diagnostic biomarkers; prediction model.
Copyright © 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.JHEP Rep. 2022 Jul 5;4(10):100529. doi: 10.1016/j.jhepr.2022.100529. eCollection 2022 Oct. JHEP Rep. 2022. PMID: 36052222 Free PMC article.
-
Testosterone and Estradiol as Novel Prognostic Indicators for HBV-Related Acute-on-Chronic Liver Failure.Front Med (Lausanne). 2021 Sep 8;8:729030. doi: 10.3389/fmed.2021.729030. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34568387 Free PMC article.
-
Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure.JHEP Rep. 2023 Jul 17;5(9):100848. doi: 10.1016/j.jhepr.2023.100848. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37583946 Free PMC article.
-
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
-
Acute-on-chronic liver failure in chronic hepatitis B: an update.Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):341-350. doi: 10.1080/17474124.2018.1426459. Epub 2018 Jan 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29334786 Review.
Cited by
-
Hepatic and extrahepatic metabolic modulation in hbv-related decompensated cirrhosis and acute-on-chronic liver failure.Virulence. 2024 Dec;15(1):2404953. doi: 10.1080/21505594.2024.2404953. Epub 2024 Sep 23. Virulence. 2024. PMID: 39312464 Free PMC article.
-
Engaging natural regulatory myeloid cells to restrict T-cell hyperactivation-induced liver inflammation via extracellular vesicle-mediated purine metabolism regulation.Theranostics. 2024 Aug 12;14(12):4874-4893. doi: 10.7150/thno.97427. eCollection 2024. Theranostics. 2024. PMID: 39239508 Free PMC article.
-
Low platelet to high-density lipoprotein ratio predicts poor short-term prognosis in hepatitis B-related acute-on-chronic liver failure.BMC Infect Dis. 2024 Aug 29;24(1):888. doi: 10.1186/s12879-024-09769-0. BMC Infect Dis. 2024. PMID: 39210311 Free PMC article.
-
Prognostic Value of High-Density Lipoprotein Cholesterol in Patients with Overt Hepatic Encephalopathy.Biomedicines. 2024 Aug 6;12(8):1783. doi: 10.3390/biomedicines12081783. Biomedicines. 2024. PMID: 39200247 Free PMC article.
-
The role of imprinting genes' loss of imprints in cancers and their clinical implications.Front Oncol. 2024 May 15;14:1365474. doi: 10.3389/fonc.2024.1365474. eCollection 2024. Front Oncol. 2024. PMID: 38812777 Free PMC article. Review.
Associated data
LinkOut - more resources
Full Text Sources